Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 8/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.33 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.32 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5079443 | 1.00 | HIF1A (0.45) | HIF1AMEN1KMT2APDK2MRGPRX4 | |
| SCHEMBL5079434 | 1.00 | HIF1A (0.45) | HIF1AMEN1KMT2APDK2MRGPRX4 | |
| SCHEMBL5075848 | 0.92 | HIF1A (0.47) | HIF1AMEN1KMT2AMRGPRX4POLB | |
| SCHEMBL5075851 | 0.92 | HIF1A (0.47) | HIF1AMEN1KMT2AMRGPRX4POLB | |
| SCHEMBL5075843 | 0.92 | HIF1A (0.47) | HIF1AMEN1KMT2AMRGPRX4POLB | |
| SCHEMBL5080502 | 0.91 | HIF1A (0.55) | HIF1AMEN1KMT2APDK2MRGPRX4 | |
| SCHEMBL5075807 | 0.91 | HIF1A (0.47) | HIF1AMEN1KMT2AMRGPRX4POLB | |
| SCHEMBL5075804 | 0.91 | HIF1A (0.47) | HIF1AMEN1KMT2AMRGPRX4POLB | |
| SCHEMBL5076967 | 0.91 | HIF1A (0.44) | HIF1AMEN1KMT2APDK2MRGPRX4 | |
| SCHEMBL5076964 | 0.91 | HIF1A (0.44) | HIF1AMEN1KMT2APDK2MRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7435844-B2 | Analogous compounds of strobilurines and their use as acaricides and insecticides | ISAGRO RICERCA S.R.L. (IT) | 2008-10-14 | — | — | US | disclosed |
| US-20060235075-A1 | Analogous compounds of strobilurines and their use as acaricides and insecticides | ISAGRO RICERCA S.R.L. (IT) | 2006-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060235075-A1 | Analogous compounds of strobilurines and their use as acaricides and insecticides | DDT, RYR1, TPMT | HIF1A 4554/4885MEN1 2918/4885KMT2A 3499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.